A Brief Discussion on the Construction of Practical Teaching System for the Traditional Chinese Medicine Resources and Development Major

China’s traditional medicine,science,and technology industry has great development potential.However,there is a problem of insufficient practitioners in the current industrial development.At the same time,the capabilities of existing practitioners do not match the demand standards.Therefore,it is necessary to actively promote the education of resources and development in Central Asia.As an institution for cultivating talents,colleges and universities must establish a practical teaching system for cultivating talents.Based on the requirements put forward by China in education,this article studies the development status of the traditional Chinese medicine resources and development major,determines the talent training goals,starts from the practical teaching aspect,and locates the industry’s requirements for the capabilities of personnel in the field of traditional Chinese medicine.It also puts forward the overall idea of the construction of the practical teaching system,summarizes the reform content of the practical teaching system,and lastly provides the specific path of the reform.

Chinese medicine practitioner turnover rate and the development of Chinese medicine in Hong Kong,China

Objective:To establish that the Hong Kong Special Administrative Region(HKSAR)government is actively promoting Chinese medicine(CM)and to examine turnover rate of Chinese medicine practitioners(CMPs)in Hong Kong,China in light of this governmental push.Methods:This study covered two major areas:reviewing CM development in Hong Kong,and assessing the turnover rate of CMPs in Hong Kong.The first part of the paper is a historical review.The investigation of turnover rate had two sections.Section 1,quantitative method,involved online questionnaires;Section 2,qualitative method comprised interviews with CMPs from different types of CM clinics to ascertain the reasons for the turnover among CMPs.Results:A total of 123 online questionnaires were received in Section 1(55 from male CMPs;66 from female CMPs;2 respondents were unwilling to disclose their sex).The proportion of CMPs who had resigned in 2018e19 was 22.8%(28),of whom 5.7%(7)had resigned twice in one year.The rates of resignation in 3 years and 5 years were up to 40.7%(50)and 56.9%(70),respectively.Six CMPs were interviewed in Section 2.Young CMPs were more likely to resign than seniors.The large gap between actual salary and expectations appeared to be the main reason for the high rate of resignation.Conclusion:HKSAR government keenly desires to promote CM in Hong Kong,however,high turnover rate of CMPs was detected even under this positive governmental support.There is an urgent need to conduct a more representative study of the reasons for the inclination of CMPs in Hong Kong.The study highlights an important issue in CM development,and these results should remind different stakeholders in the CM industry and the government that CMPs need better career prospects and support in various areas.

Opinion on pharmacology research and new drug development from precision medicine

Since President Obama announced the Precision Medicine Initiative from a national strategy perspective in his State of the Union address,precision medicine has rapidly become a world-wide hotspot and drawn global attention in the medical field.Precision medicine aims at applying genetic information of individual diseases to guide his or her diagnosis and treatment.

Quality of Life and Chinese Medicine──The Development of Health Status Measures for Chinese Medicine

Quality of Life (QOL) is a multiphase conception, including physical, mental and social factors, and can overall reflect health status of the human. At present, QOL has become a relevant measure of efficacy of treatment in clinical trials. Its use is spreading, and its importance is growing as a valid indicator of whether or not a medical treatment is

Promote Sound Development of China's Medicine Industry——Interview with Zheng Xiaoyu, Director-General of State Administration of Medicines

In the practice of instituting the system of intellectual property, medicine production is one of the key points concerning people inside and outside China. In the past six years, the medicine industry has undergone rapid development in the wake of the market economy. Although some problems cropped up in 1994, a series of laws, policies, regulations and measures has been formulated for strengthening administration. This shows how the protection of intellectual property and the deepening reform of the medicine industry are being enhanced by the Chinese government.

Study on the Inheritance,Innovation and Development of Scutellaria baicalensis Georgi in the Treatment of COVID-19

The discovery of highly effective medicine"Qingfei Paidu Decoction"for COVID-19 is a new era gift of traditional Chinese medicine to the world.The traditional Chinese medicine Scutellaria baicalensis Georgi,as a medicinal plant in the family of Labiatae,is the dominant variety of genuine medicinal material in North China.It is the leading traditional Chinese medicine in the advantageous area of agricultural products with Chinese characteristics in Shangdang of Changzhi City,and it is one of the 21 herbal medicines in the new national prescription"Qingfei Paidu Decoction"for the rapid and effective treatment of COVID-19.This paper introduces S.baicalensis Georgi and its traditional Chinese medicine GAP base,ecologically suitable planting county and medicinal value in poor areas,and studies the intellectual property resources related to S.baicalensis Georgi,such as traditional knowledge,biological genetic resources,patents,new plant varieties,geographical indications,and trademarks.This paper mainly discusses the inheritance essence,innovation and high-quality development strategy of S.baicalensis Georgi under the rural revitalization strategy and traditional Chinese medicine development strategy from the aspects of intellectual property rights,important agricultural cultural heritage,advantageous areas of characteristic agricultural products and so on.

Traditional Chinese Medicine in Malaysia: A Brief Historical Overview of Laws and Regulations

Although traditional Chinese medicine(TCM)has been a part of the Malaya and the Malaysia people’s method of maintaining health and well-being for many centuries,it was never been enrolled in the public health-care system.However,the rising cost of Western drugs and the increasing number of people frequenting TCM has driven the government to search for cheaper options and to look into its safe practice.In 1992,the government mandated all TCM herbal products to be registered with the National Pharmaceutical Control Bureau.All TCM products sold in Malaysia are now Good Manufacturing Practice certified.The government has also established a Traditional and Complementary Medicine Division within the Ministry of Health.Between 2008 and 2014,a traditional and complementary medicine unit was set up in major hospitals in all states.TCM is one of the main services offered by the unit.In 2016,the government enacted the Traditional and Complementary Medicine Act to regulate the TCM practice.Subsequently,a 10-vear blueprint has been drawn to support the development of all traditional and complementary medicines in Malaysia.This article aims to provide a brief overview on the regulatory development of TCM in Malaysia.

Improving Clinical Practice Guideline Development in Integration of Traditional Chinese Medicine and Western Medicine

Integration of traditional Chinese medicine （TCM） and Western medicine （WM）, or called as integrative medicine （IM） in China, came into being in 1950s as a new form of medicine. IM emphasizes the combination of both conventional WM and TCM alternative approaches to address all aspects of health and illness.（1） The major practice in IM includes the integration of disease diagnosis in WM and pattern classification （or syndrome differentiation） in TCM, and the integration of WM interventions and TCM interventions.

Stem cell differentiation and human liver disease

Human stem cells are scalable cell populations capable of cellular differentiation.This makes them a very attractive in vitro cellular resource and in theory provides unlimited amounts of primary cells.Such an approach has the potential to improve our understanding of human biology and treating disease.In the future it may be possible to deploy novel stem cell-based approaches to treat human liver diseases.In recent years,eff icient hepatic differentiation from human stem cells has been achieved by several research groups including our own.In this review we provide an overview of the f ield and discuss the future potential and limitations of stem cell technology.

Roles of endophytic fungi in medicinal plant abiotic stress response and TCM quality development

Medicinal plants,as medicinal materials and important drug components,have been used in traditional and folk medicine for ages.However,being sessile organisms,they are seriously affected by extreme environmental conditions and abiotic stresses such as salt,heavy metal,temperature,and water stresses.Medicinal plants usually produce specific secondary metabolites to survive such stresses,and these metabolites can often be used for treating human diseases.Recently,medicinal plants have been found to partner with endophytic fungi to form a long-term,stable,and win-win symbiotic relationship.Endophytic fungi can promote secondary metabolite accumulation in medicinal plants.The close relationship can improve host plant resistance to the abiotic stresses of soil salinity,drought,and extreme temperatures.Their symbiosis also sheds light on plant growth and active compound production.Here,we show that endophytic fungi can improve the host medicinal plant resistance to abiotic stress by regulating active compounds,reducing oxidative stress,and regulating the cell ion balance.We also identify the deficiencies and burning issues of available studies and present promising research topics for the future.This review provides guidance for endophytic fungi research to improve the ability of medicinal plants to resist abiotic stress.It also suggests ideas and methods for active compound accumulation in medicinal plants and medicinal material development during the response to abiotic stress.

Yu Dechao:Developer of Chinese Biopharmaceuticals

AS a distinguished expert on China’s Thousand Talents Program,Yu Dechao is a heavyweight in the country’s biological pharmacy.As a major founder of Oncorine,the world’s first patented anti-tumor virus therapy drug,he also invented Conbercept,China’s first monoclonal antibody drug whose global intellectual property rights it owns.

Understanding “medicine and food homology”,developing utilization in medicine functions

Chinese medicine is a very big concept of medicine. In Shennong era, medicine and food do not divide.＂Medicine and food homology＂, which is called ＂Chinese medicine and dietary application＂, refers to that many foods are drugs, and there is no absolute demarcation line between them.

The First Generation of New China Leaders' Thought of Developing Integrated Chinese and Western Medicine

The history of integrated Chinese medicine （CM） and Western medicine （WM） witnesses the development of public health under the significant support and guidance of the first generation leaders of new China who aimed at maximizing people＇s health interests. According to the available documents, it can be found out that, among the first generation of new China leaders, MAO Ze-dong, ZHOU En-lai, LIU Shao-qi, ZHU De and DENG Xiao-ping made more statements on the integration of CM and WM due to different division of labor and other historical reasons. This paper will focus on the issue to study the emergence, formation and development of their thoughts on the integration of CM and WM and analyze its process and significance, so as to enlighten the current integration of CM and WM, and even the world＇s integrative medicine.

Introduction of Institute of Medicinal Plant Development

Institute of Medicinal Plant Development (IMPLAD), affiliated with the Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), was established in August 1983. IMPLAD, headquartered in the Zhongguancun Scientific and Technical Zone, Beijing, China, owns three branch institutes with total over 333 hectares of land in the subtropical regions of southern China, located in

China President XI Jin-ping Met with Dr.Margaret Chan,Director-General of the World Health Organization,and Addressed to Promote Integrative Medicine and Chinese Medicine to Develop in Oversea Countries

China President Xi Jin-ping met with Dr. Margaret Chan, Director-General of the World Health Organization （WHO）, at the Great Hall of the People in Beijing, capital of China, Aug. 20, 2013. XI Jin-ping said that China will continue to improve public health and enhance cooperation with the WHO. The Chinese government always prioritizes its people＇s health and will make unremitting efforts to further implement reform of its public health system, Xi said. He promised that the Chinese government would continue to effectively distribute public health and medical resources in order to achieve full coverage of basic health services to all Chinese people by 2020.

Dark tea: A popular beverage with possible medicinal application

Tea is a famous beverage that is produced from leaves of Camellia sinensis.Amongst the six major tea categories in China,dark tea is the only one that involves microbial fermentation in the manufacturing process,which contributes unique flavors and functions for the tea.In the recent decade,the reports about the biofunctions of dark teas have increased rapidly.Therefore it may be the proper time to consider dark tea as one potential homology of medicine and food.In this viewpoint,our current understanding of the chemical constituents,biological activities and possible health beneficial effects of dark teas were introduced.Some future directions and challenges to the development perspectives of dark teas were also discussed.